Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00909155 · ClinicalTrials.gov registry record · NA
Brain Imaging Techniques That Predict Antidepressant Responsiveness
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00909155 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants.
The verdict
NCT00909155, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Do functional brain changes occur during Venlafaxine ER (extended release) versus Fluoxetine treatment and do changes in selective structures, such as the amygdala, predict treatment response?
Interventions
- DRUG Fluoxetine
- DRUG Venlafaxine ERT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2002-07 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00909155
The ClinicalTrials.gov registry entry for NCT00909155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluoxetine is the first listed.
NCT00909155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00909155 about?
NCT00909155 is a clinical study titled "Brain Imaging Techniques That Predict Antidepressant Responsiveness". Do functional brain changes occur during Venlafaxine ER (extended release) versus Fluoxetine treatment and do changes in selective structures, such as the amygdala, predict treatment response?
What is the current status of trial NCT00909155?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2002-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00909155?
The interventions under investigation include: Fluoxetine (DRUG), Venlafaxine ERT (DRUG).
Who is sponsoring clinical trial NCT00909155?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.